At-Home Sexually Transmitted Infection (STI) Testing Global Market Report 2026

Description

At-home sexually transmitted infection (STI) testing refers to diagnostic kits that enable individuals to collect their own samples in a private environment, which are then either sent to accredited laboratories or processed using rapid test methods at home. The primary objective is to improve accessibility, confidentiality, and convenience in STI screening, enabling early diagnosis and timely treatment while reducing stigma and barriers associated with traditional clinic-based testing.

The primary types of at-home sexually transmitted infection (STI) testing include rapid lateral flow immunoassays, molecular or nucleic acid amplification technology (NAAT)-based kits, multiplex panel testing, and other types. Rapid lateral flow immunoassays refer to simple, quick testing methods that detect the presence of specific STI markers in a sample for preliminary diagnosis at home. These solutions are based on infections such as human immunodeficiency virus (HIV), Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), syphilis, trichomoniasis, human papillomavirus (HPV), hepatitis B and C, and other infections, and they utilize sample types including blood samples, urine samples, and swab samples. The various distribution channels involved are online pharmacies and D2C platforms, retail pharmacies, public health distribution programs, and other distribution channels, and they are used by several end users such as individual consumers, healthcare providers, and public health programs.

Tariffs are impacting the at-home sexually transmitted infection (STI) testing market by increasing the cost of imported diagnostic reagents, biosensors, microfluidic chips, and semiconductor-enabled testing devices used in self-testing kits and laboratory analysis systems. This is slowing down the production and distribution of advanced molecular or nucleic acid amplification technology (NAAT)-based kits and multiplex panel testing solutions, particularly in regions dependent on imported healthcare technologies such as Asia-Pacific and Latin America. Hardware-intensive segments such as digital or connected at-home testing kits and microfluidic lab-on-chip testing kits are most affected due to global supply chain dependencies. However, tariffs are also driving local manufacturing expansion, regional supplier diversification, and increased investment in domestic diagnostic production ecosystems, creating long-term resilience in the market.

The at-home sexually transmitted infection (STI) testing market research report is one of a series of new reports from The Business Research Company that provides at-home sexually transmitted infection (STI) testing market statistics, including at-home sexually transmitted infection (STI) testing industry global market size, regional shares, competitors with a at-home sexually transmitted infection (STI) testing market share, detailed at-home sexually transmitted infection (STI) testing market segments, market trends and opportunities, and any further data you may need to thrive in the at-home sexually transmitted infection (STI) testing industry. This at-home sexually transmitted infection (STI) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The at-home sexually transmitted infection (STI) testing market size has grown rapidly in recent years. It will grow from $1.93 billion in 2025 to $2.17 billion in 2026 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to rising prevalence of sexually transmitted infections globally, increasing awareness regarding early STI diagnosis and treatment, growing penetration of online healthcare and telemedicine services, expanding public health initiatives for HIV and STI screening, increasing consumer preference for confidential home healthcare solutions.

The at-home sexually transmitted infection (STI) testing market size is expected to see rapid growth in the next few years. It will grow to $3.55 billion by 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to growing adoption of AI-enabled digital sexual health platforms, rising demand for multiplex and rapid at-home STI diagnostic kits, increasing integration of connected and app-based testing ecosystems, expanding availability of D2C healthcare distribution channels, growing focus on preventive sexual wellness and routine screening practices. Major trends in the forecast period include increasing adoption of discreet self-collection STI screening kits for private home-based testing, growing demand for rapid turnaround sexually transmitted infection diagnostic solutions, rising preference for mail-in laboratory sexual health testing services among young adults, increasing availability of multi infection at-home sexual wellness testing panels, growing expansion of online pharmacy and direct-to-consumer sexual health testing distribution channels.

The growing awareness of sexual health is expected to propel the growth of the at-home sexually transmitted infection (STI) testing market going forward. Sexual health awareness refers to individuals' understanding of STIs, their transmission pathways, prevention methods, and the importance of regular testing for early detection and treatment. The increasing focus on sexual health awareness is largely driven by public health campaigns and the progressive destigmatization of STI testing, which is encouraging more individuals to proactively seek information and testing options. The rising awareness of sexual health is supporting increased demand for at-home STI testing by motivating individuals to adopt confidential, convenient, and accessible testing solutions outside traditional clinical environments. For instance, in December 2025, according to the UK Health Security Agency, a UK-based government agency, infectious syphilis diagnoses rose by 1.7%, increasing from 9,375 cases in 2023 to 9,535 cases in 2024. Therefore, growing awareness of sexual health is contributing to and propelling the growth of the at-home sexually transmitted infection (STI) testing market.

Leading companies operating in the at-home STI testing market are focusing on developing advanced diagnostic technologies, such as instrument-free polymerase chain reaction platforms, to enhance detection accuracy, reduce turnaround time, and expand access to laboratory-grade results from home. Instrument-free polymerase chain reaction platforms refer to self-contained molecular diagnostic devices that enable users to collect samples at home and obtain highly accurate pathogen detection results without requiring traditional laboratory equipment, while integrating digital systems for secure result delivery and telehealth support. For example, in November 2025, Visby Medical, a US-based medical diagnostics company, launched its FDA-authorized at-home PCR test for sexually transmitted infections, which detects chlamydia, gonorrhea, and trichomoniasis, delivers results in approximately 30 minutes, operates as an instrument-free single-use device, and integrates with digital platforms to provide secure result reporting and virtual care follow-up. It is designed to support direct-to-consumer access, enhance molecular accuracy, improve testing convenience, and enable seamless telehealth-enabled treatment guidance.

In September 2025, Tia Health, a US-based women's healthcare platform, partnered with Molecular Testing Labs to introduce the first FDA-cleared home-collected 4-plex STI test. Through this partnership, the companies seek to improve accessibility to at-home sexually transmitted infection (STI) testing by enabling users to collect samples at home and obtain accurate, laboratory-validated results. Molecular Testing Labs is a US-based diagnostic company specializing in at-home STI testing services.

Major companies operating in the at-home sexually transmitted infection (sti) testing market are Becton Dickinson and Company (BD), Laboratory Corporation of America Holdings, Randox Laboratories Ltd, LetsGetChecked, Everly Health Inc, myLAB Box LLC, Preventx Ltd, MySTDTestKits, RapidTest. co. uk Ltd, Got Lucky Labs Inc, Biopanda Reagents Ltd, Rapid Labs Ltd, Walk-In Lab LLC, Any Lab Test Now Inc, 4U Health Ltd, Quest Diagnostics Incorporated, ACON Biotech (Hangzhou) Co. Ltd, UroSure Inc, Yoxly Ltd, Genedia Co. Ltd

North America was the largest region in the at-home sexually transmitted infection (STI) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the at-home sexually transmitted infection (STI) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the at-home sexually transmitted infection (STI) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The at-home sexually transmitted infection (STI) testing market consists of revenues earned by entities by providing services such as online consultation with healthcare professionals, digital result reporting and tracking, prescription and treatment guidance, and partner notification support. The market value includes the value of related goods sold by the service provider or included within the service offering. The at-home sexually transmitted infection (STI) testing market also includes sales of HIV self-test kits, chlamydia and gonorrhea dual test kits, syphilis rapid test kits, and HPV home screening kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

At-Home Sexually Transmitted Infection (STI) Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses at-home sexually transmitted infection (sti) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for at-home sexually transmitted infection (sti) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The at-home sexually transmitted infection (sti) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Type: Rapid Lateral Flow Immunoassays; Molecular Or Nucleic Acid Amplification Technology (NAAT)-Based Kits; Multiplex Panel Testing; Other Types
2) By Infection: Human Immunodeficiency Virus (HIV); Chlamydia Trachomatis (CT); Neisseria Gonorrhoeae (NG); Syphilis; Trichomoniasis; Human Papillomavirus (HPV); Hepatitis B And C; Other Infections
3) By Sample: Blood Samples; Urine Samples; Swab Samples
4) By Distribution: Online Pharmacies And D2C Platforms; Retail Pharmacies; Public Health Distribution Programs; Other Distributions
5) By End User: Individual Consumers; Healthcare Providers; Public Health Programs
Subsegments:
1) By Rapid Lateral Flow Immunoassays: Of Human Immunodeficiency Virus Antibody Detection; Of Syphilis Antibody Detection; Of Chlamydia Antigen Detection; Of Gonorrhea Antigen Detection; Of Hepatitis B Surface Antigen Detection
2) By Molecular Or Nucleic Acid Amplification Technology (NAAT) Based Kits: Of Human Immunodeficiency Virus Nucleic Acid Detection; Of Chlamydia Trachomatis Nucleic Acid Detection; Of Neisseria Gonorrhoeae Nucleic Acid Detection; Of Trichomonas Vaginalis Nucleic Acid Detection; Of Mycoplasma Genitalium Nucleic Acid Detection
3) By Multiplex Panel Testing: Of Combined Human Immunodeficiency Virus And Syphilis Detection; Of Combined Chlamydia And Gonorrhea Detection; Of Comprehensive Bacterial Sexually Transmitted Infection Panel; Of Comprehensive Viral Sexually Transmitted Infection Panel; Of Multi Pathogen Sexual Health Screening Panel
4) By Other Types: Self-Collection Sample Kits; Mail-In Laboratory Testing Kits; Digital Or Connected At-Home Testing Kits; Microfluidic Lab-On-Chip Testing Kits
Companies Mentioned: Becton Dickinson and Company (BD); Laboratory Corporation of America Holdings; Randox Laboratories Ltd; LetsGetChecked; Everly Health Inc; myLAB Box LLC; Preventx Ltd; MySTDTestKits; RapidTest.co.uk Ltd; Got Lucky Labs Inc; Biopanda Reagents Ltd; Rapid Labs Ltd; Walk-In Lab LLC; Any Lab Test Now Inc; 4U Health Ltd; Quest Diagnostics Incorporated; ACON Biotech (Hangzhou) Co. Ltd; UroSure Inc; Yoxly Ltd; Genedia Co. Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: HS4MAHST01_G26Q2

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. At-Home Sexually Transmitted Infection (STI) Testing Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global At-Home Sexually Transmitted Infection (STI) Testing Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. At-Home Sexually Transmitted Infection (STI) Testing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global At-Home Sexually Transmitted Infection (STI) Testing Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Artificial Intelligence & Autonomous Intelligence
- 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
- 4.1.5 Immersive Technologies (AR/VR/XR) & Digital Experiences
4.2. Major Trends
- 4.2.1 Increasing Adoption Of Discreet Self-Collection STI Screening Kits For Private Home-Based Testing
- 4.2.2 Growing Demand For Rapid Turnaround Sexually Transmitted Infection Diagnostic Solutions
- 4.2.3 Rising Preference For Mail-In Laboratory Sexual Health Testing Services Among Young Adults
- 4.2.4 Increasing Availability Of Multi Infection At-Home Sexual Wellness Testing Panels
- 4.2.5 Growing Expansion Of Online Pharmacy And Direct-To-Consumer Sexual Health Testing Distribution Channels

5. At-Home Sexually Transmitted Infection (STI) Testing Market Analysis Of End Use Industries

5.1 Individual Consumers
5.2 Healthcare Providers
5.3 Public Health Programs
5.4 Diagnostic Laboratories
5.5 Other End Users

6. At-Home Sexually Transmitted Infection (STI) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global At-Home Sexually Transmitted Infection (STI) Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global At-Home Sexually Transmitted Infection (STI) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global At-Home Sexually Transmitted Infection (STI) Testing Market Size, Comparisons And Growth Rate Analysis
7.3. Global At-Home Sexually Transmitted Infection (STI) Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global At-Home Sexually Transmitted Infection (STI) Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global At-Home Sexually Transmitted Infection (STI) Testing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. At-Home Sexually Transmitted Infection (STI) Testing Market Segmentation

9.1. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Rapid Lateral Flow Immunoassays, Molecular Or Nucleic Acid Amplification Technology (NAAT)-Based Kits, Multiplex Panel Testing, Other Types
9.2. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Infection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis (CT), Neisseria Gonorrhoeae (NG), Syphilis, Trichomoniasis, Human Papillomavirus (HPV), Hepatitis B And C, Other Infections
9.3. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Blood Samples, Urine Samples, Swab Samples
9.4. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Online Pharmacies And D2C Platforms, Retail Pharmacies, Public Health Distribution Programs, Other Distributions
9.5. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Individual Consumers, Healthcare Providers, Public Health Programs
9.6. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Sub-Segmentation Of Rapid Lateral Flow Immunoassays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Human Immunodeficiency Virus Antibody Detection, Syphilis Antibody Detection, Chlamydia Antigen Detection, Gonorrhea Antigen Detection, Hepatitis B Surface Antigen Detection
9.7. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Sub-Segmentation Of Molecular Or Nucleic Acid Amplification Technology (NAAT) Based Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Human Immunodeficiency Virus Nucleic Acid Detection, Chlamydia Trachomatis Nucleic Acid Detection, Neisseria Gonorrhoeae Nucleic Acid Detection, Trichomonas Vaginalis Nucleic Acid Detection, Mycoplasma Genitalium Nucleic Acid Detection
9.8. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Sub-Segmentation Of Multiplex Panel Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Combined Human Immunodeficiency Virus And Syphilis Detection, Combined Chlamydia And Gonorrhea Detection, Comprehensive Bacterial Sexually Transmitted Infection Panel, Comprehensive Viral Sexually Transmitted Infection Panel, Multi Pathogen Sexual Health Screening Panel
9.9. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Self-Collection Sample Kits, Mail-In Laboratory Testing Kits, Digital Or Connected At-Home Testing Kits, Microfluidic Lab-On-Chip Testing Kits

10. At-Home Sexually Transmitted Infection (STI) Testing Market Regional And Country Analysis

10.1. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global At-Home Sexually Transmitted Infection (STI) Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific At-Home Sexually Transmitted Infection (STI) Testing Market

11.1. Asia-Pacific At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China At-Home Sexually Transmitted Infection (STI) Testing Market

12.1. China At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India At-Home Sexually Transmitted Infection (STI) Testing Market

13.1. India At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan At-Home Sexually Transmitted Infection (STI) Testing Market

14.1. Japan At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia At-Home Sexually Transmitted Infection (STI) Testing Market

15.1. Australia At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia At-Home Sexually Transmitted Infection (STI) Testing Market

16.1. Indonesia At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea At-Home Sexually Transmitted Infection (STI) Testing Market

17.1. South Korea At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan At-Home Sexually Transmitted Infection (STI) Testing Market

18.1. Taiwan At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia At-Home Sexually Transmitted Infection (STI) Testing Market

19.1. South East Asia At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe At-Home Sexually Transmitted Infection (STI) Testing Market

20.1. Western Europe At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK At-Home Sexually Transmitted Infection (STI) Testing Market

21.1. UK At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany At-Home Sexually Transmitted Infection (STI) Testing Market

22.1. Germany At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France At-Home Sexually Transmitted Infection (STI) Testing Market

23.1. France At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy At-Home Sexually Transmitted Infection (STI) Testing Market

24.1. Italy At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain At-Home Sexually Transmitted Infection (STI) Testing Market

25.1. Spain At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe At-Home Sexually Transmitted Infection (STI) Testing Market

26.1. Eastern Europe At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia At-Home Sexually Transmitted Infection (STI) Testing Market

27.1. Russia At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America At-Home Sexually Transmitted Infection (STI) Testing Market

28.1. North America At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA At-Home Sexually Transmitted Infection (STI) Testing Market

29.1. USA At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada At-Home Sexually Transmitted Infection (STI) Testing Market

30.1. Canada At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America At-Home Sexually Transmitted Infection (STI) Testing Market

31.1. South America At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil At-Home Sexually Transmitted Infection (STI) Testing Market

32.1. Brazil At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East At-Home Sexually Transmitted Infection (STI) Testing Market

33.1. Middle East At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa At-Home Sexually Transmitted Infection (STI) Testing Market

34.1. Africa At-Home Sexually Transmitted Infection (STI) Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa At-Home Sexually Transmitted Infection (STI) Testing Market, Segmentation By Type, Segmentation By Infection, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. At-Home Sexually Transmitted Infection (STI) Testing Market Regulatory and Investment Landscape

36. At-Home Sexually Transmitted Infection (STI) Testing Market Competitive Landscape And Company Profiles

36.1. At-Home Sexually Transmitted Infection (STI) Testing Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. At-Home Sexually Transmitted Infection (STI) Testing Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. At-Home Sexually Transmitted Infection (STI) Testing Market Company Profiles
- 36.3.1. Becton Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Randox Laboratories Ltd Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. LetsGetChecked Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Everly Health Inc Overview, Products and Services, Strategy and Financial Analysis

37. At-Home Sexually Transmitted Infection (STI) Testing Market Other Major And Innovative Companies

myLAB Box LLC, Preventx Ltd, MySTDTestKits, RapidTest.co.uk Ltd, Got Lucky Labs Inc, Biopanda Reagents Ltd, Rapid Labs Ltd, Walk-In Lab LLC, Any Lab Test Now Inc, 4U Health Ltd, Quest Diagnostics Incorporated, ACON Biotech (Hangzhou) Co. Ltd, UroSure Inc, Yoxly Ltd, Genedia Co. Ltd

38. Global At-Home Sexually Transmitted Infection (STI) Testing Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The At-Home Sexually Transmitted Infection (STI) Testing Market

41. At-Home Sexually Transmitted Infection (STI) Testing Market High Potential Countries, Segments and Strategies

41.1 At-Home Sexually Transmitted Infection (STI) Testing Market In 2030 - Countries Offering Most New Opportunities
41.2 At-Home Sexually Transmitted Infection (STI) Testing Market In 2030 - Segments Offering Most New Opportunities
41.3 At-Home Sexually Transmitted Infection (STI) Testing Market In 2030 - Growth Strategies
- 41.3.1 Market Trend Based Strategies
- 41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations
42.2. Currencies
42.3. Historic And Forecast Inflation Rates
42.4. Research Inquiries
42.5. The Business Research Company
42.6. Copyright And Disclaimer